Inspections, Compliance, Enforcement, and Criminal Investigations
Optovue, Inc. - Close Out Letter 2/23/12
| Public Health Service Food and Drug Administration |
San Francisco District |
February 23, 2012
Mr. Jay Wai
President
Optovue, Inc.
45331 Northport Loop W.
Fremont, California 94538
Dear Mr. Wai:
The Food and Drug Administration has completed an evaluation of your corrective actions in response to our Warning Letter dated June 11, 2010. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Barbara J. Cassens
District Director
San Francisco District Office





Department of Health and Human Services

